已发表论文

男性复发性浆细胞乳腺炎的外科治疗:一例报告

 

Authors Yang T , Luo H , Zhou J, Duan Z, Jing J, Gao H 

Received 18 May 2025

Accepted for publication 19 August 2025

Published 4 September 2025 Volume 2025:18 Pages 1147—1152

DOI https://doi.org/10.2147/IMCRJ.S534479

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Thomas E Hutson

Ting Yang,1 Haijiao Luo,2 Jing Zhou,1 Zhongxu Duan,1 Jingfeng Jing,1 Han Gao1 

1Department of Breast and Thyroid, Women and Children’s Hospital of Chongqing Medical University: Chongqing Health Center for Women and Children, Chongqing, People’s Republic of China; 2School of Health Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, 15200, Malaysia

Correspondence: Han Gao, Department of Breast and Thyroid, Women and Children’s Hospital of Chongqing Medical University: Chongqing Health Center for Women and Children, Chongqing, People’s Republic of China, Email 15223323120@163.com

Introduction: Plasma Cell Mastitis (PCM) is a rare, chronic inflammatory breast disorder that primarily affects females, although there are occasional reports in males. This case report details an instance of PCM in a male patient, underscoring the diagnostic and therapeutic complexities associated with this condition.
Patient Concerns: The male patient presented with a palpable parapapillary mass, erythema, and localized breast pain.
Diagnoses: Radiological and histopathological assessments confirmed the diagnosis of PCM.
Interventions: Initial management included conservative pharmacological therapy, which was ineffective. Subsequently, the patient underwent a minimally invasive surgical intervention to address the breast lesion. However, 10 months post-surgery, a recurrence necessitated a total subcutaneous mastectomy.
Outcomes: Despite surgical interventions, the recurrence of PCM highlights the challenges in managing this condition. Complete resolution was achieved following the total subcutaneous mastectomy.
Conclusion: This case underscores the importance of recognizing and addressing PCM in male patients. It highlights the absence of a standardized clinical treatment protocol and emphasizes the necessity for personalized management approaches, especially in recurrent cases.

Keywords: plasma cell mastitis, male breast disease, inflammatory breast disease